🇺🇸 FDA
Company

OnKure

OnKure Therapeutics

OKUR pharma USA

Quick answer

OnKure is a pharma company (OKUR) headquartered in BOULDER, CO, USA with 7 tracked pipeline programs.

Pipeline (7)

project

REN001

Primary Mitochondrial Myopathy

Phase 3 · small_molecule · terminated

2 trials project

Mavodelpar

Primary Mitochondrial Myopathy

Phase 2 · small_molecule · completed

1 trials project

OKI-179 + binimetinib

RAS Mutation

Phase 2 · small_molecule · completed

1 trials project

Low Dose REN001

Fatty Acid Oxidation Disorders

Phase 1 · small_molecule · completed

1 trials project

OKI-179

Advanced Solid Tumors

Phase 1 · small_molecule · completed

1 trials project

OKI-219

Advanced Cancer

Phase 1 · small_molecule · active

1 trials project

REN001

McArdle Disease

Phase 1 · small_molecule · completed

1 trials

Patents (7)

patent

US 12252511

Process for the preparation of cyclic depsipeptides

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11739123

Process for the preparation of cyclic depsipeptides

Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11339150

Benzimidazole compounds as HDAC6 inhibitors

Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11203602

Thioester prodrugs of macrocycles as inhibitors of histone deacetylases

Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11053284

Process for the preparation of cyclic depsipeptides

Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10689419

Process for the preparation of cyclic depsipeptides

Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10100089

Process for the preparation of cyclic depsipeptides

Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)